Cargando…

The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck

Squamous cell carcinoma of the head and neck is a lethal disease with suboptimal survival outcomes and standard therapies with significant comorbidities. Whole exome sequencing data recently revealed an abundance of genetic and expression alterations in a family of enzymes known as protein methyltra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saloura, Vassiliki, Vougiouklakis, Theodore, Sievers, Cem, Burkitt, Kyunghee, Nakamura, Yusuke, Hager, Gordon, van Waes, Carter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6681457/ https://www.ncbi.nlm.nih.gov/pubmed/29884408 http://dx.doi.org/10.1016/j.oraloncology.2018.04.014

Ejemplares similares

Protein methyltransferases and demethylases dictate CD8+ T-cell exclusion in squamous cell carcinoma of the head and neck
por: Vougiouklakis, Theodore, et al.
Publicado: (2017)

Clinicopathologic significance of protein lysine methyltransferases in cancer
por: Vougiouklakis, Theodore, et al.
Publicado: (2020)

Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck Cancer
por: Burkitt, Kyunghee, et al.
Publicado: (2021)

WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2020)

Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma
por: Murali, Madhavi, et al.
Publicado: (2022)

WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2016)

SMYD3 represses tumor-intrinsic interferon response in HPV-negative squamous cell carcinoma of the head and neck
por: Nigam, Nupur, et al.
Publicado: (2023)

WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer
por: Saloura, Vassiliki, et al.
Publicado: (2017)

SMYD3: a regulator of epigenetic and signaling pathways in cancer
por: Bernard, Benjamin J., et al.
Publicado: (2021)

Role of DNA Methylation Profiles as Potential Biomarkers and Novel Therapeutic Targets in Head and Neck Cancer
por: Burkitt, Kyunghee
Publicado: (2023)

Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX
por: Vougiouklakis, Theodore, et al.
Publicado: (2018)

Genomics and advances towards precision medicine for head and neck squamous cell carcinoma
por: Van Waes, Carter, et al.
Publicado: (2017)

Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
por: Ren, Lili, et al.
Publicado: (2019)

Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma?
por: Morgan, Ethan L., et al.
Publicado: (2020)

SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells
por: Vougiouklakis, Theodore, et al.
Publicado: (2015)

Epigenetic modulation of immunotherapy and implications in head and neck cancer
por: Zhou, Liye, et al.
Publicado: (2021)

Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin
por: Burkitt, Kyunghee, et al.
Publicado: (2008)

Methyltransferase like 13 mediates the translation of Snail in head and neck squamous cell carcinoma
por: Wang, Xiaochen, et al.
Publicado: (2021)

Unraveling Regulatory Programs for NF-kappaB, p53 and MicroRNAs in Head and Neck Squamous Cell Carcinoma
por: Yan, Bin, et al.
Publicado: (2013)

Potential Therapeutic Significance of Laminin in Head and Neck Squamous Carcinomas
por: Meireles Da Costa, Nathalia, et al.
Publicado: (2021)

Therapeutic Targeting of MYC in Head and Neck Squamous Cell Carcinoma
por: Liu, Shuo, et al.
Publicado: (2022)

Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC)
por: Morgan, Ethan L., et al.
Publicado: (2023)

Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous Carcinoma
por: Toni, Tiffany, et al.
Publicado: (2023)

Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma
por: Wu, Yaping, et al.
Publicado: (2019)

Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma—A Review
por: Devaraja, K., et al.
Publicado: (2023)

Unusual death due to a bleeding from a varicose vein: a case report
por: Fragkouli, Kleio, et al.
Publicado: (2012)

Anti-Tumor Immunity in Head and Neck Cancer: Understanding the Evidence, How Tumors Escape and Immunotherapeutic Approaches
por: Allen, Clint T., et al.
Publicado: (2015)

Prostaglandin-like material extracted from squamous carcinomas of the head and neck.
por: Bennett, A., et al.
Publicado: (1980)

Identification of m6A methyltransferase-related genes predicts prognosis and immune infiltrates in head and neck squamous cell carcinoma
por: Zhang, Yijian, et al.
Publicado: (2021)

Prognostic and Therapeutic Potential of Nuclear Receptors in Head and Neck Squamous Cell Carcinomas
por: Knauer, Shirley K.
Publicado: (2009)

Identification of potential therapeutic targets in human head & neck squamous cell carcinoma
por: Han, Jing, et al.
Publicado: (2009)

Therapeutic implications of tumor free margins in head and neck squamous cell carcinoma
por: Backes, Clara, et al.
Publicado: (2017)

Therapeutic strategies of different HPV status in Head and Neck Squamous Cell Carcinoma
por: Sun, Yingming, et al.
Publicado: (2021)

Unilateral Cervical Polyneuropathies following Concurrent Bortezomib, Cetuximab, and Radiotherapy for Head and Neck Cancer
por: Elghouche, Alhasan, et al.
Publicado: (2016)

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
por: Cavalieri, Stefano, et al.
Publicado: (2021)

Some mechanisms of local bone destruction by squamous carcinomas of the head and neck.
por: Tsao, S. W., et al.
Publicado: (1981)

Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-κB and other signal transcription factors in head and neck squamous cell carcinoma
por: Yan, Bin, et al.
Publicado: (2007)

Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer
por: Yan, Bin, et al.
Publicado: (2013)

Impact of p16 Status and Anatomical Site in Anti-PD-1 Immunotherapy-Treated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Patients
por: Clancy, Kate, et al.
Publicado: (2021)

Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas
por: An, Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qj4m7cl7t7nt6ahbca31t2a0he